亚临床微钙化与炎症和颈动脉粥样硬化发展的关联:一项双示踪剂PET/CT研究
本研究纳入115名受试者(73名健康志愿者、42名心血管疾病风险者),行18F-NaF与18F-FDG PET/CT,定量测量左右颈总动脉平均血池校正平均标准化摄取值(aSUVmean)。结果显示风险者较健康志愿者NaF与FDG摄取分别高10-22%和16-27%(双侧动脉,p<0.05);NaF aSUVmean与年龄、BMI相关,FDG aSUVmean与BMI等相关;NaF aSUVmean随10年CVD风险升高而增加(仅左颈总动脉,p=0.003),两种示踪剂aSUVmean均随血栓栓塞风险升高而增加(双侧动脉,p<0.05),NaF与FDG aSUVmean间无相关性(p>0.05)。作者认为18F-NaF PET/CT可能作为颈动脉微钙化和亚临床动脉粥样硬化的预后工具,而18F-FDG PET/CT的效用仍不确定。
要点
- 风险者较健康志愿者颈动脉NaF与FDG摄取分别高10-22%和16-27%(双侧,p<0.05)。
- NaF aSUVmean随10年CVD风险升高而增加(仅左颈总动脉,p=0.003),FDG未见显著趋势。
- NaF与FDG aSUVmean间无相关性(p>0.05);NaF PET/CT可能作为预后工具。
核心结论
- 18F-NaF PET/CT可能作为颈动脉微钙化和亚临床动脉粥样硬化的预后工具,而18F-FDG PET/CT的效用仍不确定。
研究设计与样本
- 队列研究纳入115名受试者,包括73名健康志愿者和42名心血管疾病风险者,均行18F-NaF与18F-FDG PET/CT成像。
- 放射性示踪剂摄取通过测量平均血池校正平均标准化摄取值(aSUVmean)进行定量评估。
- 临床试验注册号为NCT01724749(CAMONA)。
主要发现
- 与健康志愿者相比,风险者双侧颈动脉NaF摄取高10-22%、FDG摄取高16-27%(p<0.05)。
- 多变量回归中,NaF aSUVmean与年龄和BMI相关(p<0.01);FDG aSUVmean与BMI(p≤0.01)、纤维蛋白原(仅左颈总动脉,p<0.01)和总胆固醇(仅右颈总动脉,p=0.02)相关。
- NaF aSUVmean随10年CVD风险升高而增加(仅左颈总动脉,p=0.003),FDG未见显著趋势。
- NaF和FDG aSUVmean均随血栓栓塞风险升高而增加(双侧动脉,p<0.05)。
- NaF与FDG aSUVmean之间未观察到相关性(p>0.05)。
关键数值与推荐
- 风险者较健康志愿者NaF摄取高10-22%(双侧颈动脉,p<0.05)。
- 风险者较健康志愿者FDG摄取高16-27%(双侧颈动脉,p<0.05)。
- NaF aSUVmean与年龄和BMI相关(p<0.01)。
- FDG aSUVmean与BMI相关(p≤0.01),与纤维蛋白原相关(仅左颈总动脉,p<0.01),与总胆固醇相关(仅右颈总动脉,p=0.02)。
- NaF aSUVmean随10年CVD风险升高而增加(仅左颈总动脉,p=0.003);NaF和FDG aSUVmean均随血栓栓塞风险升高而增加(双侧动脉,p<0.05)。
临床怎么用
- 作者认为18F-NaF PET/CT可能作为颈动脉微钙化和亚临床动脉粥样硬化的预后工具。
- 作者认为18F-FDG PET/CT的效用仍不确定。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Carotid artery atherosclerosis, a significant manifestation of cardiovascular disease (CVD) and leading cause of stroke, develops through a gradual process of arterial inflammation and calcification. This study explores the relationship between arterial inflammation (18 F-FDG PET/CT) and vascular calcification (18 F-NaF PET/CT) in the left and right common carotid arteries (LCC/RCC) and their association with CVD and thromboembolic risk in patients with subclinical atherosclerosis. METHODS: A cohort of 115 subjects (73 healthy volunteers, 42 at-risk for CVD) underwent 18 F-NaF and 18 F-FDG PET/CT imaging. Radiotracer uptake was quantitatively assessed by measuring the average blood-pool-corrected mean standardized uptake value (aSUVmean). RESULTS: Relative to healthy volunteers, at-risk subjects had greater uptake of NaF and FDG (10-22% and 16-27% higher, respectively, in both arteries, p < 0.05). On multivariate regression, NaF aSUVmean correlated with age and BMI (p < 0.01), and FDG aSUVmean correlated with BMI (p ≤ 0.01), fibrinogen (p < 0.01 in LCC only), and total cholesterol (p = 0.02 in RCC only). NaF aSUVmean increased with elevated 10-year CVD risk (p = 0.003 in LCC only), while no significant trend was seen for FDG. NaF and FDG aSUVmean increased with elevated thromboembolic risk in both arteries (p < 0.05). No correlations between NaF and FDG aSUVmean were observed (p > 0.05). CONCLUSION: 18 F-NaF PET/CT may serve as a prognostic tool for carotid microcalcification and subclinical atherosclerosis, while the utility of 18 F-FDG PET/CT remains uncertain. CLINICAL TRIAL REGISTRATION: "Cardiovascular Molecular Calcification Assessed by 18F-NaF PET CT (CAMONA)", NCT01724749, https://clinicaltrials.gov/study/NCT01724749 .
引用
- Patil S, Kata R, Teichner E, et al. Associations of subclinical microcalcification and inflammation with carotid atheroma development: a dual-tracer PET/CT study. Eur J Nucl Med Mol Imaging. 2025. PMID: 39939531. doi:10.1007/s00259-025-07127-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。